UNSPSC 85693572: Supplement right humeral head with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right humeral head with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PUC37Z

UNSPSC 85693572 Supplement right humeral head with autologous tissue substitute, percutaneous approach is a Commodity code that nominally describes a specific orthopedic surgical procedure, but the recent state and local opportunities posted under this code show no direct alignment with surgical implant procurement or orthopedic medical device supply. Instead, the opportunities center on medical evaluation, occupational health surveillance, pharmacy benefit management, healthcare staffing, and surgical care networks — none of which involve the procurement or supply of humeral head implants or orthopedic tissue substitutes. The code shows little relevant recent activity in state and local procurement for the product it nominally describes.

The recent opportunities tagged to this code span diverse healthcare service categories issued by a mix of city retirement offices, county health systems, state transportation departments, and county probation agencies across Arizona, California, Washington, and Texas. Representative solicitations include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026), the Washington State Department of Transportation's RFP for occupational medical surveillance services (RFP20260825, due October 9, 2026), and the County of Santa Clara Health System's RFQ for temporary health professional staffing across ancillary clinical specialties (RFSQHHSFY270052, due October 7, 2026). These opportunities reflect healthcare administration and staffing procurement rather than medical device or implant supply, indicating a systematic mismatch between the code's nominal scope and recent state and local transactional activity under it.